These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 4783020)

  • 21. Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk/benefit ratio.
    Lanse SB; Arnold GL; Gowans JD; Kaplan MM
    Dig Dis Sci; 1985 Feb; 30(2):104-9. PubMed ID: 3967557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
    Geronemus RG; Auerbach R; Tobias H
    Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver biopsy in methotrexate treatment.
    Zachariae H; Schiodt T
    Acta Derm Venereol; 1971; 51(3):215-20. PubMed ID: 4103033
    [No Abstract]   [Full Text] [Related]  

  • 25. Cirrhosis associated with methotrexate treatment of psoriasis.
    Coe RO; Bull FE
    JAMA; 1968 Nov; 206(7):1515-20. PubMed ID: 5695945
    [No Abstract]   [Full Text] [Related]  

  • 26. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis.
    Ashton RE; Millward-Sadler GH; White JE
    J Invest Dermatol; 1982 Oct; 79(4):229-32. PubMed ID: 7130740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longterm methotrexate therapy in rheumatoid arthritis: a review.
    Kremer JM
    J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():25-8. PubMed ID: 3913773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate induced liver cirrhosis. Studies including serial liver biopsies during continued treatment.
    Zachariae H; Kragballe K; Søgaard H
    Br J Dermatol; 1980 Apr; 102(4):407-12. PubMed ID: 7387883
    [No Abstract]   [Full Text] [Related]  

  • 30. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H; Schrøder H; Foged E; Søgaard H
    Acta Derm Venereol; 1987; 67(4):336-40. PubMed ID: 2445154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psoriasis, methotrexate, and cirrhosis.
    JAMA; 1970 Apr; 212(2):314-5. PubMed ID: 5467236
    [No Abstract]   [Full Text] [Related]  

  • 32. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA; Aithal GP
    Am J Clin Dermatol; 2005; 6(6):357-63. PubMed ID: 16343024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cirrhosis following prolonged treatment of psoriasis with methotrexate orally.
    Robeson JA; Spenney J; Hirschowitz BI
    South Med J; 1972 Apr; 65(4):453-6. PubMed ID: 5028402
    [No Abstract]   [Full Text] [Related]  

  • 34. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate therapy for psoriasis. Guideline revisions.
    Roenigk HH; Maibach HI; Weinstein GP
    Arch Dermatol; 1973 Jul; 108(1):35. PubMed ID: 4716739
    [No Abstract]   [Full Text] [Related]  

  • 36. Methotrexate hepatotoxicity in psoriasis--comparison of different dose regimens.
    Dahl MG; Gregory MM; Scheuer PJ
    Br Med J; 1972 Mar; 1(5801):654-6. PubMed ID: 5015292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
    Te HS; Schiano TD; Kuan SF; Hanauer SB; Conjeevaram HS; Baker AL
    Am J Gastroenterol; 2000 Nov; 95(11):3150-6. PubMed ID: 11095334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver biopsies in psoriatics--complications and evaluation.
    Creswell SN; Burrows D
    Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
    van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
    Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate hepatotoxicity in psoriasis.
    Ryan TJ; Sadler GH; Guerrier C; Vickers HR
    Br Med J; 1972 Apr; 2(5808):296. PubMed ID: 5022031
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.